Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Content Partners
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Get Data
    • Macro-Economic News
    • Research Analysis
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus

Moderna says its Covid vaccine generates strong immune response in 6-11 year-olds

Chidinma Anyalewechi by Chidinma Anyalewechi
October 26, 2021
in Coronavirus
Moderna says its Covid vaccine generates strong immune response in 6-11 year-olds
Share on FacebookShare on TwitterShare on Linkedin

On Monday, drugmaker, Moderna Inc disclosed that a study of children aged 6 to 11 revealed that a smaller dosage of its Covid-19 vaccine is safe and generates a strong immune response.

The study showed that half the dosage given to adults, which is two 50-microgram doses of the vaccine, produced higher antibody levels than those seen in young adults.

In the company’s press release, citing early data from a phase 2/3 trial, it was discovered that in the children on which the study was conducted, the antibody levels were 1.5 times higher than those in young adults.

RelatedPosts

Canada to ease travel requirements as COVID-19 infection rates decline

US Supreme Court blocks Biden’s vaccine mandate for large businesses

Why this matters

This development comes a day before an important FDA advisory committee meeting scheduled to discuss the advantages and otherwise of recommending the Pfizer and BioNTech’s vaccine for kids aged 5 to 11. Based on the resolutions reached in the meeting, the FDA could authorize the shots within days of the meeting, and as early as next week, the Centers for Disease Control and Prevention could authorize it.

Also, according to the company, the shots were generally well-tolerated in young kids, with the most common side effects ranging between fatigue, headache, fever, and injection-site pain. The vaccine was tested on more than 4,700 children.

News continues after this ad


The drug maker says plans are underway to submit the obtained data to the Food and Drug Administration (FDA), European Medicines Agency and other health regulators in the “near term.”

Moderna CEO Stephane Bancel said in a statement, “We look forward to filing with regulators globally and remain committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all ages”.

News continues after this ad


Officials at FDA have said that Pfizer’s vaccine appears highly effective at preventing symptomatic infections in elementary school-age children.

The reactions and responses towards vaccination of children has majorly been that of anxiety as many parents say they are anxious to get their children vaccinated as kids started the new school year with the delta variant still on a high side across America.

According to the American Academy of Pediatrics, the number of new Covid cases in kids over the past month remains exceptionally high, with more than 1.1 million child cases added in the past six weeks.

Related

Tags: Covid-19 vaccineFDAFood and Drug AdministrationModerna IncStephane Bancel

Comments 1

  1. ahmad isah says:
    October 26, 2021 at 9:45 am

    hello

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

inq
avatrade
Stanbic bank
Mega Millions
UBN
Hot forex
Access Bank
Bankers Committee
First bank






    Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

    Recent News

    • Lagos moves to establish RoW for Opebi-Mende Link Bridge, to serve demolition notices
    • Ghanaians endure hardship as country’s Misery Index jumps to 60.8 in July
    • FoodCo launches 16th outlet in Ikoyi, Lagos

    Follow us on social media:

    Recent News

    Lagos warns against indiscriminate physical developments on Lekki regional road

    Lagos moves to establish RoW for Opebi-Mende Link Bridge, to serve demolition notices

    August 15, 2022
    Ghanaians endure hardship as country’s Misery Index jumps to 60.8 in July

    Ghanaians endure hardship as country’s Misery Index jumps to 60.8 in July

    August 15, 2022
    • ABOUT US
    • CONTACT US
    • PRODUCTS
    • ANDROID APP
    • iOS APP
    • DISCLAIMER
    • CAREERS
    • PRIVACY POLICY

    © 2022 Nairametrics

    No Result
    View All Result
    • Home
    • Exclusives
      • Financial Analysis
      • Corporate Stories
      • Interviews
      • Investigations
      • Metrics
    • Markets
      • Cryptos
      • Commodities
      • Equities
        • Dividends
        • Stock Market
      • Fixed Income
      • Market Views
      • Securities
    • Industries
      • Company News
      • Consumer Goods
      • Content Partners
      • Corporate deals
      • Corporate Press Releases
      • Energy
      • Entertainment
      • Financial Services
      • Hospitality & Travel
      • Manufacturing
      • Real Estate and Construction
      • Tech News
    • Economy
      • Get Data
      • Macro-Economic News
      • Research Analysis
    • Business News
    • Financial Literacy
      • Career tips
      • Personal Finance
    • Lifestyle
      • Billionaire Watch
      • Profiles
    • Opinions
      • Blurb
      • Op-Eds

    © 2022 Nairametrics

    Social Media Auto Publish Powered By : XYZScripts.com